Precise Stratification of Genetic Risk of Ovarian Function Impairment

Inclusion Criteria:

1. Women who meet the diagnosis of premature ovarian insufficiency (POI), diminishedovarian reserve (DOR) or early menopause and hope to find out the risk of prematureovarian impairment and clarify the cause of premature ovarian impairment;
2. premature ovarian insufficiency (POI): the age of female is less than 40 yearsold, with menopause or sparse menstruation for 4 months, and basal FSH > 25IU / Lfor two consecutive times with an interval of more than 4 weeks.
3. Diminshed ovarian reserve (DOR): before the age of 40, the number of antralfollicles in both ovaries is less than 6, or AMH is less than 1.1ng/ml, or basalFSH is greater than 10 IU/L.
4. Early menopause: women who enter menopause between the age of 40 and 45.
5. Informed consent, voluntary test.

Exclusion Criteria:

1. Chromosome karyotype abnormality;
2. Iatrogenic ovarian injury: history of radiotherapy, chemotherapy (reproductive toxicdrugs such as alkylating agents) and ovarian surgery;
3. Ovarian mass: there is abnormal echo in the ovary under ultrasound, and the maximumdiameter is greater than 4cm.
4. Pregnant and lactating women;
5. Polycystic ovary syndrome, hyperprolactinemia, hyperandrogenemia, hypothyroidism,adrenal dysfunction and other endocrine diseases affect ovulation;
6. Patients with cardiovascular, liver, kidney, hematopoietic system and other seriousprimary diseases and psychosis;
7. Patients who are participating in other clinical trials or have participated in otherclinical trials in the past month;
8. Other patients determined by the investigator to be unsuitable for participation inthis study.